Mobile Platform for Optimizing Wellness and Engagement in Recovery
University of Michigan
50 participants
Dec 8, 2025
INTERVENTIONAL
Conditions
Summary
This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the feasibility and acceptability of digital CM for OUD-AUD recovery, while also planning for broader implementation.
Eligibility
Inclusion Criteria5
- Participants must be enrolled in the Michigan Medicaid program
- Opioid agonist treatment (OAT): Participants must have initiated OAT with buprenorphine or methadone
- Participants must have an OAT prescription and Alcohol use disorder (AUD) based on self-report measure during screening
- Participants must have regular access to a working smartphone and internet connection.
- Participants must have a reliable mailing address to receive study supplies (e.g., salivary drug tests).
Exclusion Criteria6
- Primary Medicare Coverage: Individuals that are dual-eligible for Medicaid and Medicare and aged 65 or older, due to limited availability of Medicaid claims data for this group
- Individuals that cannot voluntarily provide informed consent themselves for any reason, including legal incompetency
- Individuals with substantial cognitive impairment that would interfere with study participation
- Individuals unable to read or understand English
- Individuals experiencing active suicidality or psychosis.
- Individuals with a planned admission to residential treatment or incarceration during the study period.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will use a version of the app for 6-months. Participants in this group may earn rewards for completing recovery-related activities and for abstinence from drugs and alcohol. During the 6 months this will include: random saliva drug tests, breathalyzer tests, and video selfies, completing surveys and questionnaires through the app, and receiving rewards on a debit card for abstinent tests, surveys, and activities. Additionally, participants will complete follow-up at approximately 9 months after randomization.
Participants will use a version of the app for 6-months focussed on wellness. During the 6 months this will include: random requests to do saliva drug tests, breathalyzer tests, and video selfies, complete surveys and questionnaires through the app, and receive rewards on a debit card for completing tests, surveys, and activities. Participants in this group may also earn rewards for completing study activities like tests and surveys. Additionally, participants will complete follow-up at approximately 9 months after randomization.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07178990